<?xml version='1.0' encoding='UTF-8'?>
<rss xmlns:arxiv="http://arxiv.org/schemas/atom" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" version="2.0">
  <channel>
    <title>q-bio.OT updates on arXiv.org</title>
    <link>http://rss.arxiv.org/rss/q-bio.OT</link>
    <description>q-bio.OT updates on the arXiv.org e-print archive.</description>
    <atom:link href="http://rss.arxiv.org/rss/q-bio.OT" rel="self" type="application/rss+xml"/>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <language>en-us</language>
    <lastBuildDate>Fri, 07 Nov 2025 05:01:01 +0000</lastBuildDate>
    <managingEditor>rss-help@arxiv.org</managingEditor>
    <pubDate>Fri, 07 Nov 2025 00:00:00 -0500</pubDate>
    <skipDays>
      <day>Saturday</day>
      <day>Sunday</day>
    </skipDays>
    <item>
      <title>Mathematical and Computational Nuclear Oncology: Toward Optimized Radiopharmaceutical Therapy via Digital Twins</title>
      <link>https://arxiv.org/abs/2511.03755</link>
      <description>arXiv:2511.03755v1 Announce Type: new 
Abstract: This article presents the general framework of theranostic digital twins (TDTs) in computational nuclear medicine, designed to support clinical decision-making and improve cancer patient prognosis through personalized radiopharmaceutical therapies (RPTs). It outlines potential clinical applications of TDTs and proposes a roadmap for successful implementation. Additionally, the chapter provides a conceptual overview of the current state of the art in the mathematical and computational modeling of RPTs, highlighting key challenges and the strategies being pursued to address them.</description>
      <guid isPermaLink="false">oai:arXiv.org:2511.03755v1</guid>
      <category>q-bio.OT</category>
      <pubDate>Fri, 07 Nov 2025 00:00:00 -0500</pubDate>
      <arxiv:announce_type>new</arxiv:announce_type>
      <dc:rights>http://arxiv.org/licenses/nonexclusive-distrib/1.0/</dc:rights>
      <arxiv:DOI>10.1016/j.cpet.2025.09.005</arxiv:DOI>
      <dc:creator>Marc Ryhiner, Yangmeihui Song, Babak Saboury, Gerhard Glatting, Arman Rahmim, Kuangyu Shi</dc:creator>
    </item>
    <item>
      <title>Current validation practice undermines surgical AI development</title>
      <link>https://arxiv.org/abs/2511.03769</link>
      <description>arXiv:2511.03769v1 Announce Type: new 
Abstract: Surgical data science (SDS) is rapidly advancing, yet clinical adoption of artificial intelligence (AI) in surgery remains severely limited, with inadequate validation emerging as a key obstacle. In fact, existing validation practices often neglect the temporal and hierarchical structure of intraoperative videos, producing misleading, unstable, or clinically irrelevant results. In a pioneering, consensus-driven effort, we introduce the first comprehensive catalog of validation pitfalls in AI-based surgical video analysis that was derived from a multi-stage Delphi process with 91 international experts. The collected pitfalls span three categories: (1) data (e.g., incomplete annotation, spurious correlations), (2) metric selection and configuration (e.g., neglect of temporal stability, mismatch with clinical needs), and (3) aggregation and reporting (e.g., clinically uninformative aggregation, failure to account for frame dependencies in hierarchical data structures). A systematic review of surgical AI papers reveals that these pitfalls are widespread in current practice, with the majority of studies failing to account for temporal dynamics or hierarchical data structure, or relying on clinically uninformative metrics. Experiments on real surgical video datasets provide the first empirical evidence that ignoring temporal and hierarchical data structures can lead to drastic understatement of uncertainty, obscure critical failure modes, and even alter algorithm rankings. This work establishes a framework for the rigorous validation of surgical video analysis algorithms, providing a foundation for safe clinical translation, benchmarking, regulatory review, and future reporting standards in the field.</description>
      <guid isPermaLink="false">oai:arXiv.org:2511.03769v1</guid>
      <category>q-bio.OT</category>
      <pubDate>Fri, 07 Nov 2025 00:00:00 -0500</pubDate>
      <arxiv:announce_type>new</arxiv:announce_type>
      <dc:rights>http://arxiv.org/licenses/nonexclusive-distrib/1.0/</dc:rights>
      <dc:creator>Annika Reinke, Ziying O. Li, Minu D. Tizabi, Pascaline Andr\'e, Marcel Knopp, Mika M. Rother, Ines P. Machado, Maria S. Altieri, Deepak Alapatt, Sophia Bano, Sebastian Bodenstedt, Oliver Burgert, Elvis C. S. Chen, Justin W. Collins, Olivier Colliot, Evangelia Christodoulou, Tobias Czempiel, Adrito Das, Reuben Docea, Daniel Donoho, Qi Dou, Jennifer Eckhoff, Sandy Engelhardt, Gabor Fichtinger, Philipp Fuernstahl, Pablo Garc\'ia Kilroy, Stamatia Giannarou, Stephen Gilbert, Ines Gockel, Patrick Godau, Jan G\"odeke, Teodor P. Grantcharov, Tamas Haidegger, Alexander Hann, Makoto Hashizume, Charles Heitz, Rebecca Hisey, Hanna Hoffmann, Arnaud Huaulm\'e, Paul F. J\"ager, Pierre Jannin, Anthony Jarc, Rohit Jena, Yueming Jin, Leo Joskowicz, Luc Joyeux, Max Kirchner, Axel Krieger, Gernot Kronreif, Kyle Lam, Shlomi Laufer, Jo\"el L. Lavanchy, Gyusung I. Lee, Robert Lim, Peng Liu, Hani J. Marcus, Pietro Mascagni, Ozanan R. Meireles, Beat P. Mueller, Lars M\"undermann, Hirenkumar Nakawala, Nassir Navab, Abdourahmane Ndong, Juliane Neumann, Felix Nickel, Marco Nolden, Chinedu Nwoye, Namkee Oh, Nicolas Padoy, Thomas Pausch, Micha Pfeiffer, Tim R\"adsch, Hongliang Ren, Nicola Rieke, Dominik Rivoir, Duygu Sarikaya, Samuel Schmidgall, Matthias Seibold, Silvia Seidlitz, Lalith Sharan, Jeffrey H. Siewerdsen, Vinkle Srivastav, Raphael Sznitman, Russell Taylor, Thuy N. Tran, Matthias Unberath, Fons van der Sommen, Martin Wagner, Amine Yamlahi, Shaohua K. Zhou, Aneeq Zia, Amin Madani, Danail Stoyanov, Stefanie Speidel, Danail A. Hashimoto, Fiona R. Kolbinger, Lena Maier-Hein</dc:creator>
    </item>
  </channel>
</rss>
